Page last updated: 2024-11-07

spironolactone and Remission, Spontaneous

spironolactone has been researched along with Remission, Spontaneous in 6 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.

Research Excerpts

ExcerptRelevanceReference
"N(G)-nitro-L-arginine-methyl ester (L-NAME)-induced hypertension is associated with protein remodeling of the left ventricle."7.74Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension. ( Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F, 2007)
"Primary aldosteronism (PA) is mainly caused by aldosterone-producing adenoma and idiopathic bilateral adrenal hyperplasia (IHA)."5.38Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. ( Beuschlein, F; Bidlingmaier, M; Degenhart, C; Fischer, E; Jung, P; Reincke, M, 2012)
"N(G)-nitro-L-arginine-methyl ester (L-NAME)-induced hypertension is associated with protein remodeling of the left ventricle."3.74Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension. ( Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F, 2007)
"Primary aldosteronism (PA) is mainly caused by aldosterone-producing adenoma and idiopathic bilateral adrenal hyperplasia (IHA)."1.38Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. ( Beuschlein, F; Bidlingmaier, M; Degenhart, C; Fischer, E; Jung, P; Reincke, M, 2012)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Mai, X3
Kometani, M3
Yoneda, T3
Fischer, E1
Beuschlein, F1
Degenhart, C1
Jung, P1
Bidlingmaier, M1
Reincke, M1
Simko, F1
Potácová, A1
Pelouch, V1
Paulis, L1
Matúsková, J1
Krajcírovicová, K1
Pechánová, O1
Adamcová, M1
Kokenge, F1
Liedtke, R1
Zepf, S1
Olbing, H1
Greifer, I1
Bennett, BP1
Bernstein, J1
Spitzer, A1
Gabriele, C1
Gabriele, S1
Bandiermonte, Z1

Reviews

1 review available for spironolactone and Remission, Spontaneous

ArticleYear
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
    International journal of molecular sciences, 2022, Nov-10, Volume: 23, Issue:22

    Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids;

2022

Other Studies

5 other studies available for spironolactone and Remission, Spontaneous

ArticleYear
Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry.
    Clinical endocrinology, 2012, Volume: 76, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Mineralocorti

2012
Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
    Physiological research, 2007, Volume: 56 Suppl 2

    Topics: Animals; Arginine; Blood Pressure; Collagen; Hypertension; Hypertrophy, Left Ventricular; Male; Mine

2007
[A contribution on diagnostic and therapy of myxoedema coma (author's transl)].
    Medizinische Klinik, 1975, Aug-01, Volume: 70, Issue:31

    Topics: Aged; Coma; Female; Humans; Hyperaldosteronism; Myxedema; Remission, Spontaneous; Spironolactone; Tr

1975
Idiopathic membranous nephropathy in children.
    Kidney international, 1973, Volume: 3, Issue:6

    Topics: Adolescent; Age Factors; Aminohippuric Acids; Basement Membrane; Biopsy; Child; Child, Preschool; Cr

1973
[Prednisone and immunosuppressive agents in the therapy of nephrotic syndrome in infancy].
    Minerva pediatrica, 1971, Apr-21, Volume: 23, Issue:16

    Topics: Child; Child, Preschool; Drug Synergism; Female; Humans; Immunosuppressive Agents; Infant; Male; Nep

1971